Tilray Brands (TLRY) Other Working Capital Changes (2017 - 2026)
Tilray Brands (TLRY) posted Other Working Capital Changes of -$3.7 million for Q1 2026, down 1508.81% on a QoQ basis from $261000.0 in Q4 2025, and up 23.2% year-over-year from -$3.0 million in Q1 2025.
Tilray Brands (TLRY) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Tilray Brands' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at -$3.7 million for Q1 2026.
- Quarterly Other Working Capital Changes rose 23.2% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $3.7 million (up 201.64% YoY) and the FY2025 annual result came in at $8.3 million, up 163.23% from the prior year.
- Other Working Capital Changes was -$3.7 million for Q1 2026 at Tilray Brands, down from $261000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $34.9 million in Q3 2022 and bottomed at -$35.8 million in Q2 2023.
- A 5-year average of -$881235.3 and a median of -$524000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 2706.52% — and 2023, when it jumped 565.77%.
- Tilray Brands' Other Working Capital Changes stood at -$27.1 million in 2022, then soared by 68.95% to -$8.4 million in 2023, then soared by 93.78% to -$524000.0 in 2024, then jumped by 149.81% to $261000.0 in 2025, then tumbled by 1508.81% to -$3.7 million in 2026.
- Business Quant data shows TLRY's Other Working Capital Changes at -$3.7 million in Q1 2026, $261000.0 in Q4 2025, and $7.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -3.68 Mn |
| Feb 28, 2026 | -3.68 Mn |
| Feb 28, 2026 | -3.68 Mn |
| Nov 30, 2025 | 261,000.00 |
| Nov 30, 2025 | 261,000.00 |
| Nov 30, 2025 | 261,000.00 |
| Aug 31, 2025 | 7.13 Mn |
| Aug 31, 2025 | 7.13 Mn |
| Aug 31, 2025 | 7.13 Mn |
| May 31, 2025 | 6,000.00 |
| May 31, 2025 | 6,000.00 |
| May 31, 2025 | 6,000.00 |
| Feb 28, 2025 | -4.79 Mn |
| Feb 28, 2025 | -4.79 Mn |
| Feb 28, 2025 | -4.79 Mn |
| Nov 30, 2024 | -524,000.00 |
| Nov 30, 2024 | -524,000.00 |
| Nov 30, 2024 | -524,000.00 |
| Aug 31, 2024 | 13.57 Mn |
| Aug 31, 2024 | 13.57 Mn |